What ZS Pharma, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Nohra Guy P | Director | Dec 17 | Disposition to Issuer · D | −1,000 | $90.00 | −$90K | 0 |
| Babler Martin | Director | Dec 17 | Disposition to Issuer · D | −1,000 | $90.00 | −$90K | 0 |
| Keyser D Jeffrey | Chief Operating Officer | Dec 17 | Tender Offer · U | −216,169 | $90.00 | −$19.5M | 0 |
| Keyser D Jeffrey | Chief Operating Officer | Dec 17 | Disposition to Issuer · D | −12,353 | $90.00 | −$1.11M | 0 |
| Popovits Kimberly J | Director | Dec 17 | Disposition to Issuer · D | −1,000 | $90.00 | −$90K | 0 |
| Smith Cynthia | Chief Commercial Officer | Dec 17 | Disposition to Issuer · D | −12,598 | $90.00 | −$1.13M | 0 |
| Akkaraju Srinivas | Director | Dec 17 | Disposition to Issuer · D | −1,000 | $90.00 | −$90K | 0 |
| Alexander Robert | Chief Executive Officer | Dec 17 | Disposition to Issuer · D | −30,750 | $90.00 | −$2.77M | 0 |
| Guillem Alvaro | President | Dec 17 | Tender Offer · U | −186,923 | $90.00 | −$16.8M | 0 |
| Guillem Alvaro | President | Dec 17 | Disposition to Issuer · D | −15,654 | $90.00 | −$1.41M | 0 |
| Whiting John M | Director | Dec 17 | Disposition to Issuer · D | −1,000 | $90.00 | −$90K | 0 |
| Asbury Mark | Chief Legal Officer | Dec 17 | Disposition to Issuer · D | −6,921 | $90.00 | −$623K | 0 |
| Tomasi Adam | See Remarks | Dec 17 | Disposition to Issuer · D | −12,599 | $90.00 | −$1.13M | 0 |
| Rasmussen Henrik S Md | Chief Medical Officer | Dec 17 | Disposition to Issuer · D | −3,000 | $90.00 | −$270K | 0 |
| Devon Park Bioventures Lp | 10% owner | Dec 17 | Tender Offer · U | −2,576,724 | $90.00 | −$232M | 0 |
| Devon Park Bioventures Lp | 10% owner | Dec 17 | Tender Offer · U | −9,748 | $90.00 | −$877K | 0 |
| Ostro Marc | Director | Dec 17 | Tender Offer · U | −2,576,724 | $90.00 | −$232M | 0 |
| Ostro Marc | Director | Dec 17 | Tender Offer · U | −9,748 | $90.00 | −$877K | 2,576,724 |
| Guillem Alvaro | President | Dec 10 | Exercise / conversion · M | +9,154 | $10.92 | +$100K | 196,077 |
| Keyser D Jeffrey | Chief Operating Officer | Dec 09 | Exercise / conversion · M | +9,154 | $10.92 | +$100K | 225,323 |
Loading...